Trial Profile
Effects of omega-3 ethylester concentrate on arterial compliance in obese patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Nov 2012
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Atherosclerosis; Coronary artery disease
- Focus Pharmacodynamics
- 13 Nov 2012 New trial record
- 12 May 2012 Results presented at the 19th European Congress on Obesity.